Thomas Niel

Thomas Niel

InvestorPlace Contributor

Expertise: Micro-Cap Stocks, Shareholder Activist Stocks, Value Stocks

Education: Bachelors in Accounting, CFA Program Participant (Completed Level I in 2017)

About Thomas:
Thomas Niel is an investment writer at InvestorPlace. With a professional background in accounting and financial analysis, his understanding of both words and figures pays dividends when writing clear, concise stock analysis.

A value investor at heart, Thomas looks at the fundamentals. Peer analysis and earnings multiples rarely tell the whole story. But, Thomas believes valuation metrics are a great starting point to separate the wheat from the chaff.

His work has appeared at several websites, including Seeking Alpha and TipRanks. Outside of investment research, Thomas provides inbound marketing content to the investment management industry.

You can follow Thomas on Twitter and check out his track record on TipRanks.

Recent Articles

ViacomCBS Stock Is a Diamond in the Rough

By Thomas Niel, InvestorPlace Contributor

It may not get back above $100 per share, but VIAC stock is a screaming buy at this point due to its potential positive catalysts.

Why Now’s the Time to Start Scooping Up Cardano

By Thomas Niel, InvestorPlace Contributor

With Alonzo/Goguen upgrades just around the corner, today may be the perfect time to start accumulating a position in Cardano.

Consider Sundial Stock a Buy, as the Latest Reddit Wave Dissipates

By Thomas Niel, InvestorPlace Contributor

In short, what's the best move? SNDL stock still has big downside risk. But, considering its "to the moon" potential, once it's clear U.S. pot legalization is coming, consider it a buy following the recent pullback.

Orphazyme A/S May Look Like a Long Shot, but Things Aren’t That Dire

By Thomas Niel, InvestorPlace Contributor

How far could ORPH stock climb if it gets squeezed? Maybe not back above $77 per share. But, a move back to $15-$20 per share could be attainable. For investors with a healthy risk appetite, and a stomach for volatility, consider it a buy at today's prices (around $7.25 per share).

Consider AST SpaceMobile Stock a Worthwhile Moonshot

By Thomas Niel, InvestorPlace Contributor

Risk remains high, as its technology could fail to deliver, sending shares cratering towards zero. There may only be a moderate chance of hitting its long-term projections. Even so, hopping into ASTS stock now, after its pop, but while it's still on the launching pad, may be a high risk worth taking.

Load More